REPORT HIGHLIGHTS

This report provides:
An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types, with a focus on insulin syringes and vials.
Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.
Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.
Patent identifications for insulin as a drug, along with its delivery methods.

STUDY OBJECTIVES

BCC Research’s objective in carrying out this study is to provide an overview of the current and future characteristics of the global market for emerging insulin drugs and delivery technologies. The fundamental objective is to present a comprehensive analysis and identify the future direction of insulin drugs and delivery devices as important tools in treating diabetes with well-tolerated delivery devices.This report explores present and future strategies within the insulin drug and delivery market, which includes syringes, pumps, pens and many newer methods. The market’s improvisation, setbacks and needs are also discussed. The classifications, comparisons and usage of different insulin types and devices are presented as well.A detailed analysis of insulin drugs and delivery industry structure has been conducted. Revenues are broken down by type, as well as by region. Sales figures are estimated for the five-year period from 2013 through 2018.Applications for insulin drugs and delivery are also discussed in a separate section, with emphasis on their usage in treating different types of diabetes. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles. , leading to a steady market for these technologies.Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.Companies’ acquisition strategies and collaborations are covered in this report. This study also discusses the strength and weaknesses of each technology type in light of the new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

This study contributes to the areas of market growth for insulin drug and delivery manufacturers and users. It will be of interest to pharmaceutical biotechnical companies, research institutes, hospitals and physicians.

SCOPE OF THE STUDY

The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018.The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY

Both primary and secondary research methodologies were used in the preparation of this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with manufacturers of enzyme inhibitors technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study. including manufacturers of insulin drugs and delivery technologies and their users in hospitals and medical centers. Data were gathered from various industry sources. BCC Research spoke with officials within the industry and also consulted newsletters; company literature; product literature; and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

Table Of Contents

CHAPTER 1 INTRODUCTION 2
STUDY OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
CONTRIBUTIONS OF THE STUDY AND FOR WHOM 2
SCOPE OF THE STUDY 3
METHODOLOGY 3
INFORMATION SOURCES 3
ABOUT THE AUTHOR 3
RELATED BCC RESEARCH REPORTS 4
BCC ONLINE SERVICES 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
THROUGH 2018 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
2011-2018 ($ MILLIONS) 8
CHAPTER 3 OVERVIEW 10
DIABETES OVERVIEW 10
DIABETES CLASSIFICATION 10
TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11
EPIDEMIOLOGY 13
TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH
RESPECT TO 2000 13
TYPE 1 DIABETES MELLITUS MANAGEMENT 14
INSULIN 15
HISTORY OF INSULIN ISOLATION AND THE DEVELOPMENT OF ITS ANALOGS 15
TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15
STRUCTURE OF INSULIN 16
INSULIN BIOSYNTHESIS 16
INSULIN TYPES 17
TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19
TREATMENT PROTOCOL 20
Multiple Daily Injections 20
TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21
Continuous Subcutaneous Insulin Infusion and Insulin Pump Therapy 21
TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22
TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR
VARIOUS INSULIN DELIVERY SYSTEMS 23
TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25
ADMINISTRATION ROUTES 26
TABLE 9 INSULIN ADMINISTRATION ROUTES 27
CHAPTER 4 REGULATORY ASPECTS 29
APPROVALS FOR INSULIN DRUGS 29
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials
TABLE 10 INSULIN DRUG APPROVALS, 2009-MARCH 2013 29
APPROVALS GRANTED FOR INSULIN DEVICES 30
TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN
DEVICES, 2009-MARCH 2013 30
PREMARKET NOTIFICATION OR 510(K) CLEARANCE 32
TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN
DEVICES, 2009-MARCH 2013 33
SAFETY ALERTS AND RECALLS 34
TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 34
TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 35
CHAPTER 5 NEW DEVELOPMENTS 41
NEW TECHNOLOGIES FOR INSULIN DELIVERY 42
INSULIN INHALERS 42
INSULIN SPRAY 42
IMPLANTABLE INSULIN PUMPS 42
TRANSDERMAL PATCH 42
PRODUCT DEVELOPMENT 43
TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43
MERGERS AND ACQUISITIONS 45
TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND
ACQUISITIONS 46
LICENSING, PARTNERSHIPS, AND AGREEMENTS 47
TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS
AND DELIVERY DEVICES 48
PIPELINE PRODUCTS 51
TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51
CHAPTER 6 GLOBAL MARKETS 56
MARKET BY TYPE 57
MARKET OVERVIEW 57
MARKET REVENUE 58
TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
THROUGH 2018 ($ MILLIONS) 58
FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
2011-2018 ($ MILLIONS) 59
MARKET SHARE 59
TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012
(%) 59
FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60
MARKET BY REGION 60
MARKET OVERVIEW 61
MARKET REVENUE 62
TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 62
FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
2011-2018 ($ MILLIONS) 63
MARKET SHARE 63
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials
TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
(%) 63
FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63
INSULIN SYRINGES AND VIALS 64
Market Overview 64
Market Revenue 64
TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 65
FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($
MILLIONS) 65
Market Share 65
TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
INSULIN PENS 66
Market Overview 67
Market Revenue 67
TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68
FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS) 68
Market Share 68
TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
INSULIN PUMPS 69
Market Overview 70
Market Revenue 71
TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 71
FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 72
Market Share 72
TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
MARKET BY APPLICATIONS 73
TYPE 1 DIABETES 73
TYPE 2 DIABETES 74
GESTATIONAL DIABETES 75
MARKET OVERVIEW 75
MARKET REVENUE 76
TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
THROUGH 2018 ($ MILLIONS) 76
FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY
APPLICATION, 2011-2018 ($ MILLIONS) 76
MARKET SHARE 77
TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY
APPLICATION, 2012 (%) 77
CHAPTER 7 INSULIN SYRINGE AND VIAL MARKET ANALYSIS 80
MARKET BY TYPE 80
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials
U-100 INSULIN SYRINGE 81
U-40 INSULIN SYRINGES 81
MARKET OVERVIEW 81
MARKET REVENUE FOR INSULIN SYRINGES 82
TABLE 31 GLOBAL INSULIN SYRINGE MARKET BY TYPE, THROUGH 2018 ($
MILLIONS) 82
FIGURE 13 GLOBAL INSULIN SYRINGE MARKET BY TYPE, 2011-2018 ($ MILLIONS) 82
INSULIN SYRINGE MARKET SHARE 83
TABLE 32 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
FIGURE 14 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
INSULIN SYRINGE AND VIAL MARKET REVENUE 84
TABLE 33 GLOBAL INSULIN SYRINGE AND VIAL MARKET, THROUGH 2018 ($
MILLIONS) 84
FIGURE 15 GLOBAL INSULIN SYRINGE AND VIAL MARKET, 2011-2018 ($ MILLIONS) 84
INSULIN SYRINGE AND VIAL MARKET SHARES 85
TABLE 34 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
FIGURE 16 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
MARKET BY REGION 86
MARKET OVERVIEW 86
INSULIN SYRINGE MARKET REVENUE 86
TABLE 35 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
FIGURE 17 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
U-100 Insulin Syringe Market Revenue 87
TABLE 36 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 88
FIGURE 18 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($
MILLIONS) 88
U-40 Insulin Syringe Market Revenue 88
TABLE 37 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 89
FIGURE 19 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($
MILLIONS) 89
INSULIN SYRINGE AND VIAL MARKET REVENUE 90
TABLE 38 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 90
FIGURE 20 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 91
INSULIN SYRINGE MARKET SHARES 91
TABLE 39 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
FIGURE 21 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
INSULIN SYRINGE AND VIAL MARKET SHARES 92
TABLE 40 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
FIGURE 22 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
MARKET BY APPLICATION 93
TYPE 1 DIABETES 93
TYPE 2 DIABETES 94
GESTATIONAL DIABETES 94
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials
MARKET OVERVIEW 94
MARKET REVENUE FOR SYRINGES 95
TABLE 41 INSULIN SYRINGE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 95
FIGURE 23 INSULIN SYRINGE MARKET BY APPLICATION, 2011-2018 ($ MILLIONS) 96
SYRINGE MARKET SHARES 96
TABLE 42 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
FIGURE 24 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
SYRINGE AND VIAL MARKET REVENUE 97
TABLE 43 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
FIGURE 25 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, 2011-2018 ($
MILLIONS) 98
SYRINGE AND VIAL MARKET SHARES 98
TABLE 44 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
FIGURE 26 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
INDUSTRY STRUCTURE 99
MARKET LEADERS 100
TABLE 45 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN SYRINGES AND
VIALS 100
INSULIN SYRINGE MARKET SHARES 101
TABLE 46 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
FIGURE 27 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
INSULIN SYRINGE AND VIAL MARKET SHARES 102
TABLE 47 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 102
FIGURE 28 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 103
CHAPTER 8 PATENT ANALYSIS 105
PATENTS BY YEAR 105
TABLE 48 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 105
FIGURE 29 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 105
PATENTS BY TYPE 106
TABLE 49 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106
FIGURE 30 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106
PATENTS BY COMPANY 107
TABLE 50 U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013 107
PATENTS BY COUNTRY 109
TABLE 51 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 109
FIGURE 31 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 110
PATENTS BY ASSIGNEE 110
TABLE 52 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110
FIGURE 32 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110
CHAPTER 9 CURRENT SITUATION 113
MARKET TRENDS 114
INSULIN PUMPS 114
Artificial Pancreas 114
Closed-Loop Insulin Pump 114
INSULIN PENS 115
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials
INSULIN SYRINGES 115
MODERN INSULIN AND ALTERNATIVE DELIVERY METHODS 115
ORAL INSULIN 115
NASAL INSULIN SPRAY 116
BIOSIMILAR INSULIN 116
OVERALL MARKET DRIVERS FOR INSULIN DELIVERY DEVICE MARKET 116
FACTORS GOVERNING THE INSULIN DELIVERY DEVICE MARKET 117
COLLABORATIONS, MERGERS AND AQUISITIONS 117
CHAPTER 10 COMPANY PROFILES 121
ADOCIA 121
ANIMAS CORPORATION 121
ANTRIABIO 122
BECTON, DICKINSON AND COMPANY 123
BIOCON LIMITED 123
BIODEL INC. 124
DEBIOTECH 125
ELI LILLY 125
ETERNITY HEALTHCARE 126
F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG) 127
GENEREX BIOTECHNOLOGY CORPORATION 127
HALOZYME THERAPEUTICS INC. 128
INSULINE MEDICAL 128
INSULUTION ABM 129
LIFESCAN 129
MANNKIND 130
MARINA BIOTECH INC. 131
MEDTRONIC INC. 132
MICROPORT SCIENTIFIC CORPORATION 132
MIDASOL THERAPEUTICS (JOINT VENTURE OF MIDATECH LTD. AND MONOSOL
RX) 133
NOVO NORDISK 133
ORAMED PHARMACEUTICALS INC. 134
PHOSPHAGENICS LIMITED 135
SANOFI 135
SENSILE MEDICAL AG 136
THERMALIN DIABETES INC. 137
XERIS PHARMACEUTICALS 138
YPSOMED HOLDING AG 138
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials

LIST OF TABLES

SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
THROUGH 2018 ($ MILLIONS) 7
TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11
TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH
RESPECT TO 2000 13
TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15
TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19
TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21
TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22
TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR
VARIOUS INSULIN DELIVERY SYSTEMS 23
TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25
TABLE 9 INSULIN ADMINISTRATION ROUTES 27
TABLE 10 INSULIN DRUG APPROVALS, 2009-MARCH 2013 29
TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN
DEVICES, 2009-MARCH 2013 30
TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN
DEVICES, 2009-MARCH 2013 33
TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 34
TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 35
TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43
TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND
ACQUISITIONS 46
TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND
DELIVERY DEVICES 48
TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51
TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
THROUGH 2018 ($ MILLIONS) 58
TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012 (%) 59
TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 62
TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
(%) 63
TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018
($ MILLIONS) 65
TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68
TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 71
TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
THROUGH 2018 ($ MILLIONS) 76
TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
TABLE 31 GLOBAL INSULIN SYRINGE MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 82
TABLE 32 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
TABLE 33 GLOBAL INSULIN SYRINGE AND VIAL MARKET, THROUGH 2018 ($
MILLIONS) 84
TABLE 34 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials
TABLE 35 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
TABLE 36 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 88
TABLE 37 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 89
TABLE 38 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018
($ MILLIONS) 90
TABLE 39 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
TABLE 40 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
TABLE 41 INSULIN SYRINGE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS) 95
TABLE 42 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
TABLE 43 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
TABLE 44 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
TABLE 45 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN SYRINGES AND
VIALS 100
TABLE 46 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
TABLE 47 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 102
TABLE 48 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 105
TABLE 49 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106
TABLE 50 U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013 107
TABLE 51 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 109
TABLE 52 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110
HLC156A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes
and Vials

LIST OF FIGURES

SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
2011-2018 ($ MILLIONS) 8
FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
2011-2018 ($ MILLIONS) 59
FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60
FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
2011-2018 ($ MILLIONS) 63
FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63
FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($
MILLIONS) 65
FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS) 68
FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 72
FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
2011-2018 ($ MILLIONS) 76
FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
FIGURE 13 GLOBAL INSULIN SYRINGE MARKET BY TYPE, 2011-2018 ($ MILLIONS) 82
FIGURE 14 INSULIN SYRINGE MARKET SHARES BY TYPE, 2012 (%) 83
FIGURE 15 GLOBAL INSULIN SYRINGE AND VIAL MARKET, 2011-2018 ($ MILLIONS) 84
FIGURE 16 INSULIN SYRINGE AND VIAL MARKET SHARES BY TYPE, 2012 (%) 85
FIGURE 17 GLOBAL INSULIN SYRINGE MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 87
FIGURE 18 GLOBAL U-100 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($
MILLIONS) 88
FIGURE 19 GLOBAL U-40 INSULIN SYRINGE MARKET BY REGION, 2011-2018 ($
MILLIONS) 89
FIGURE 20 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 91
FIGURE 21 INSULIN SYRINGE MARKET SHARES BY REGION, 2012 (%) 91
FIGURE 22 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 92
FIGURE 23 INSULIN SYRINGE MARKET BY APPLICATION, 2011-2018 ($ MILLIONS) 96
FIGURE 24 INSULIN SYRINGE MARKET SHARES BY APPLICATION, 2012 (%) 96
FIGURE 25 INSULIN SYRINGE AND VIAL MARKET BY APPLICATION, 2011-2018 ($
MILLIONS) 98
FIGURE 26 INSULIN SYRINGE AND VIAL MARKET SHARES BY APPLICATION, 2012 (%) 99
FIGURE 27 INSULIN SYRINGE MANUFACTURER MARKET SHARES, 2012 (%) 101
FIGURE 28 INSULIN SYRINGE AND VIAL MANUFACTURER MARKET SHARES, 2012 (%) 103
FIGURE 29 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 105
FIGURE 30 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 106
FIGURE 31 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 110
FIGURE 32 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 110

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Wound Care Market Outlook

Global Wound Care Market Outlook

  • $ 8 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

Analysis of Wound Care Technologies The global wound care market is at a growth stage. It is driven by the increasingly aging population as well as rising rates of diabetes and obesity. These chronic health ...

World Medical Disposables Market

World Medical Disposables Market

  • $ 6 400
  • Industry report
  • September 2014
  • by Freedonia

World medical disposables demand to increase 6.6% annually through 2018 The Freedonia Group projects that world demand for disposable medical supplies will increase 6.6 percent yearly to nearly $245 billion ...

Machine Health Monitoring Market by Product (vibration monitoring, thermography, ultrasound emission, lubricating oil analysis, corrosion monitoring, motor current signature analysis), Component, Application and Geography - Global Forecast to 2014 - 2020

Machine Health Monitoring Market by Product (vibration monitoring, thermography, ultrasound emission, lubricating oil analysis, corrosion monitoring, motor current signature analysis), Component, Application and Geography - Global Forecast to 2014 - 2020

  • $ 4 650
  • Industry report
  • June 2014
  • by MarketsandMarkets

Machine health monitoring is the best way of maintenance to meet the production requirements of in a timely or efficient manner. It is the process of monitoring the health of a machine with the intent ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.